NCT00050362View on ClinicalTrials.gov

Rofecoxib and Bupivacaine to Prevent Pain After Third Molar (Wisdom Tooth) Extraction

PHASE2CompletedINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

December 31, 2002

Study Completion Date

October 31, 2004

Conditions
PainTooth Extraction
Interventions
DRUG

Rofecoxib and Bupivacaine

Trial Locations (1)

20892

National Institute of Dental And Craniofacial Research (NIDCR), Bethesda

All Listed Sponsors
lead

National Institute of Dental and Craniofacial Research (NIDCR)

NIH

NCT00050362 - Rofecoxib and Bupivacaine to Prevent Pain After Third Molar (Wisdom Tooth) Extraction | Biotech Hunter | Biotech Hunter